What we found on the web about Amgen
Amgen Inc. (NASDAQ: AMGN, SEHK: 4332) is an international biotechnology company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the largest ...
Kirin-Amgen, Inc. v Hoechst Marion Roussel Ltd. [1] is a decision by the House of Lords of England and Wales. The judgment was issued on 21 October 2004 and relates to the scope to ...
Amgen is among the biggest of the biotech big'uns, and it's determined to get even bigger. The company uses cellular biology and medicinal chemistry...
Get detailed information on Amgen Inc. (AMGN) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest company ...
Nov 7: Your Best Chance to Profit in 2009 - MotleyFool.com: Nov 6: Biotech Stock Mailbag: Poniard Predictions - at TheStreet.com: Nov 5: This Top Stock Is a Winner - MotleyFool.com
UCSD SEA Surveys Web Site ... Welcome The UCSD Amgen Scholars Program is an eight-week, full-time research experience for undergraduates, supported by the Amgen Foundation.
For the second time, Amgen has been named one of The Sunday Times’ Top 100 “Best Companies to Work For” in the UK. Amgen was ranked 56 among the top 100 mid-sized workplaces
HTTP/1.1 200 OK Server: Sun-ONE-Web-Server/6.1 Date: Sun, 08 Nov 2009 04:36:00 GMT Content-length: 2897 Content-Type: text/html Set-Cookie: JSESSIONID ...
Amgen’s patient assistance programs are a continuum of services designed to provide access through free goods and other support services to qualifying uninsured and under-insured ...
Here is what users have to say about Amgen

Amgen Inc. (nasdaq: AMGN, hkex: 4332) is an international biotechnology company headquartered in Thousand Oaks, California. Located in the Conejo Valley, Amgen is the largest independent biotech firm. The company employs approximately 14,000 staff members including the 125 Allied-Barton Security staff and A-post personnel in 2007. Its products include Epogen, Aranesp, Enbrel, Kineret, Neulasta, Neupogen, Sensipar / Mimpara and Nplate. Epogen and Neupogen (the company's first products on the market) were the two most successful biopharmaceutical products at the time of their respective releases.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Amgen
Post Chronicle
Sales of the drugs, including Amgen's Aranesp and Epogen and Johnson & Johnson's Procrit, have fallen sharply since a late 2006 study by J&J showed a higher risk of death and cardiovascular complications for aggressively treated patients.